Trial Profile
Dose proportionality of 4 single doses of levodopa/carbidopa (IXP066; RYTARI) in volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Dec 2015
Price :
$35
*
At a glance
- Drugs Levodopa/carbidopa (Primary)
- Indications Parkinson's disease
- Focus Pharmacokinetics
- 07 Dec 2015 New trial record
- 25 Nov 2015 Results published in the Clinical Neuropharmacology